W Edward Visser Selected Research

Allan-Herndon-Dudley syndrome

1/2021	Monocarboxylate Transporter 8 Deficiency: From Pathophysiological Understanding to Therapy Development.
12/2019	Novel mutations in SLC16A2 associated with a less severe phenotype of MCT8 deficiency.
1/2019	Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial.
1/2017	Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W Edward Visser Research Topics

Disease

8	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 09/2009
6	Hypothyroidism 01/2022 - 01/2018
5	follicular Thyroid cancer 02/2022 - 01/2018
5	Thyrotoxicosis 01/2022 - 01/2017
4	Allan-Herndon-Dudley syndrome 01/2021 - 01/2017
3	Hyperthyroidism 01/2022 - 02/2014
3	Constipation 01/2021 - 08/2014
3	Thyroid Diseases (Thyroid Disease) 01/2020 - 02/2014
2	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2020
2	Muscle Hypotonia (Hypotonia) 08/2021 - 03/2016
2	Graves Disease (Basedow Disease) 05/2021 - 02/2014
2	Papillary Thyroid Cancer 01/2021 - 01/2018
2	Intellectual Disability (Idiocy) 01/2019 - 04/2016
2	Megalencephaly 01/2017 - 08/2014
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 08/2021
1	Hyperphagia (Overeating) 08/2021
1	Pigmented Nevus (Melanocytic Nevus) 01/2021
1	COVID-19 07/2020
1	Infections 07/2020
1	Neutropenia 07/2020
1	Neoplasms (Cancer) 04/2019
1	Sepsis (Septicemia) 01/2019
1	Thyroid Hormone Resistance Syndrome (Thyroid Hormone Resistance) 11/2018
1	Autoimmune Diseases (Autoimmune Disease) 09/2017
1	Anemia 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Mood Disorders (Mood Disorder) 01/2016
1	Apraxias (Dyspraxia) 08/2014
1	Goiter 02/2014
1	Autoimmune Hypothyroidism 02/2014
1	Thyroiditis 02/2014
1	Genetic Risk Score 02/2014
1	Dyslipidemias (Dyslipidemia) 07/2013

Drug/Important Bio-Agent (IBA)

15	Thyroid HormonesIBA 01/2022 - 08/2014
9	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 09/2009
5	RacivirIBA 02/2022 - 01/2018
4	IodineIBA 01/2022 - 04/2014
4	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2022 - 03/2016
3	AntibodiesIBA 01/2022 - 02/2014
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 08/2021 - 02/2014
2	Thyroglobulin FDA Link 01/2022 - 01/2022
2	Hormones (Hormone)IBA 01/2022 - 08/2021
2	Antithyroid Agents (Antithyroid Drugs)IBA 05/2021 - 07/2020
2	Iodide Peroxidase (Deiodinase)IBA 01/2021 - 02/2014
2	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2021 - 01/2017
2	Creatine Kinase (Creatine Phosphokinase)IBA 08/2014 - 07/2013
1	Co-Repressor ProteinsIBA 01/2022
1	Cyclin D1IBA 01/2021
1	AcidsIBA 01/2021
1	Reverse TriiodothyronineIBA 01/2020
1	Somatostatin Receptors (Somatostatin Receptor)IBA 04/2019
1	Radioisotopes (Radionuclides)IBA 04/2019
1	somatostatin receptor 2IBA 04/2019
1	177Lu-octreotateIBA 04/2019
1	Peptide Receptors (Peptide Receptor)IBA 04/2019
1	Tyrosine Kinase InhibitorsIBA 04/2019
1	3,3',5-triiodothyroacetic acid (Triac)IBA 01/2019
1	ElementsIBA 01/2019
1	Thyroid Hormone Receptors beta (TR beta)IBA 11/2018
1	Leucine (L-Leucine)FDA Link 11/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2017
1	Thyroxine-Binding GlobulinIBA 04/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 08/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 07/2013

Therapy/Procedure

5	Therapeutics 01/2022 - 04/2019
1	Thyroidectomy 05/2021
1	Aftercare (After-Treatment) 08/2014